Oculis Holding AG Net Income
| OCS Stock | 28.74 0.26 0.91% |
As of the 10th of February, Oculis Holding holds the Semi Deviation of 1.72, risk adjusted performance of 0.1822, and Coefficient Of Variation of 458.14. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Oculis Holding, as well as the relationship between them. Please check Oculis Holding AG jensen alpha and downside variance to decide if Oculis Holding AG is priced some-what accurately, providing market reflects its current price of 28.74 per share. Given that Oculis Holding has jensen alpha of 0.5818, we recommend you to check out Oculis Holding AG's recent market performance to make sure the company can sustain itself at a future point.
Oculis Holding Total Revenue |
|
Gross Profit | Market Capitalization | Revenue | Earnings Share (2.78) | Quarterly Revenue Growth 0.125 |
| Last Reported | Projected for Next Year | ||
| Net Loss | -77.2 M | -81.1 M | |
| Net Loss | -13.4 M | -14.1 M | |
| Net Loss | -77.3 M | -81.2 M | |
| Net Loss | (2.44) | (2.56) | |
| Net Income Per E B T | 1.15 | 1.10 |
Oculis | Net Income | Build AI portfolio with Oculis Stock |
The evolution of Net Income for Oculis Holding AG provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Oculis Holding compares to historical norms and industry peers.
Latest Oculis Holding's Net Income Growth Pattern
Below is the plot of the Net Income of Oculis Holding AG over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Oculis Holding AG financial statement analysis. It represents the amount of money remaining after all of Oculis Holding AG operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Oculis Holding's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Oculis Holding's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (85.94 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Oculis Net Income Regression Statistics
| Arithmetic Mean | (32,570,033) | |
| Coefficient Of Variation | (90.87) | |
| Mean Deviation | 24,551,223 | |
| Median | (14,873,000) | |
| Standard Deviation | 29,596,331 | |
| Sample Variance | 875.9T | |
| Range | 73.9M | |
| R-Value | (0.78) | |
| Mean Square Error | 364.7T | |
| R-Squared | 0.61 | |
| Significance | 0.0002 | |
| Slope | (4,576,422) | |
| Total Sum of Squares | 14015.1T |
Oculis Net Income History
Other Fundumenentals of Oculis Holding AG
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Oculis Holding Net Income component correlations
Oculis Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Oculis Holding is extremely important. It helps to project a fair market value of Oculis Stock properly, considering its historical fundamentals such as Net Income. Since Oculis Holding's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Oculis Holding's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Oculis Holding's interrelated accounts and indicators.
Click cells to compare fundamentals
Is there potential for Biotechnology market expansion? Will Oculis introduce new products? Factors like these will boost the valuation of Oculis Holding. Anticipated expansion of Oculis directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about Oculis Holding listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.78) | Revenue Per Share | Quarterly Revenue Growth 0.125 | Return On Assets | Return On Equity |
Understanding Oculis Holding AG requires distinguishing between market price and book value, where the latter reflects Oculis's accounting equity. The concept of intrinsic value - what Oculis Holding's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Oculis Holding's price substantially above or below its fundamental value.
It's important to distinguish between Oculis Holding's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Oculis Holding should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Oculis Holding's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Oculis Holding 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Oculis Holding's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Oculis Holding.
| 11/12/2025 |
| 02/10/2026 |
If you would invest 0.00 in Oculis Holding on November 12, 2025 and sell it all today you would earn a total of 0.00 from holding Oculis Holding AG or generate 0.0% return on investment in Oculis Holding over 90 days. Oculis Holding is related to or competes with Xencor, Kodiak Sciences, AnaptysBio, UroGen Pharma, Phathom Pharmaceuticals, Nurix Therapeutics, and Nektar Therapeutics. Oculis Holding is entity of United States More
Oculis Holding Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Oculis Holding's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Oculis Holding AG upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.4 | |||
| Information Ratio | 0.1834 | |||
| Maximum Drawdown | 16.37 | |||
| Value At Risk | (3.08) | |||
| Potential Upside | 5.79 |
Oculis Holding Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Oculis Holding's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Oculis Holding's standard deviation. In reality, there are many statistical measures that can use Oculis Holding historical prices to predict the future Oculis Holding's volatility.| Risk Adjusted Performance | 0.1822 | |||
| Jensen Alpha | 0.5818 | |||
| Total Risk Alpha | 0.295 | |||
| Sortino Ratio | 0.2156 | |||
| Treynor Ratio | 2.25 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Oculis Holding's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Oculis Holding February 10, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1822 | |||
| Market Risk Adjusted Performance | 2.26 | |||
| Mean Deviation | 1.95 | |||
| Semi Deviation | 1.72 | |||
| Downside Deviation | 2.4 | |||
| Coefficient Of Variation | 458.14 | |||
| Standard Deviation | 2.82 | |||
| Variance | 7.95 | |||
| Information Ratio | 0.1834 | |||
| Jensen Alpha | 0.5818 | |||
| Total Risk Alpha | 0.295 | |||
| Sortino Ratio | 0.2156 | |||
| Treynor Ratio | 2.25 | |||
| Maximum Drawdown | 16.37 | |||
| Value At Risk | (3.08) | |||
| Potential Upside | 5.79 | |||
| Downside Variance | 5.75 | |||
| Semi Variance | 2.94 | |||
| Expected Short fall | (2.16) | |||
| Skewness | 0.8148 | |||
| Kurtosis | 2.29 |
Oculis Holding AG Backtested Returns
Oculis Holding appears to be very steady, given 3 months investment horizon. Oculis Holding AG maintains Sharpe Ratio (i.e., Efficiency) of 0.25, which implies the firm had a 0.25 % return per unit of risk over the last 3 months. By analyzing Oculis Holding's technical indicators, you can evaluate if the expected return of 0.73% is justified by implied risk. Please evaluate Oculis Holding's Coefficient Of Variation of 458.14, semi deviation of 1.72, and Risk Adjusted Performance of 0.1822 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Oculis Holding holds a performance score of 19. The company holds a Beta of 0.27, which implies not very significant fluctuations relative to the market. As returns on the market increase, Oculis Holding's returns are expected to increase less than the market. However, during the bear market, the loss of holding Oculis Holding is expected to be smaller as well. Please check Oculis Holding's downside variance, as well as the relationship between the accumulation distribution and market facilitation index , to make a quick decision on whether Oculis Holding's historical price patterns will revert.
Auto-correlation | 0.68 |
Good predictability
Oculis Holding AG has good predictability. Overlapping area represents the amount of predictability between Oculis Holding time series from 12th of November 2025 to 27th of December 2025 and 27th of December 2025 to 10th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Oculis Holding AG price movement. The serial correlation of 0.68 indicates that around 68.0% of current Oculis Holding price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.68 | |
| Spearman Rank Test | 0.59 | |
| Residual Average | 0.0 | |
| Price Variance | 10.44 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Oculis Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Oculis Holding AG reported net income of (85.94 Million). This is 125.18% lower than that of the Biotechnology sector and 222.69% lower than that of the Health Care industry. The net income for all United States stocks is 115.05% higher than that of the company.
Oculis Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Oculis Holding's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Oculis Holding could also be used in its relative valuation, which is a method of valuing Oculis Holding by comparing valuation metrics of similar companies.Oculis Holding is currently under evaluation in net income category among its peers.
Oculis Holding Current Valuation Drivers
We derive many important indicators used in calculating different scores of Oculis Holding from analyzing Oculis Holding's financial statements. These drivers represent accounts that assess Oculis Holding's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Oculis Holding's important valuation drivers and their relationship over time.
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Market Cap | 289.2M | 305.5M | 282.3M | 623.5M | 561.2M | 285.1M | |
| Enterprise Value | 357.2M | 408.8M | 244.6M | 597.0M | 537.3M | 310.2M |
Oculis Holding ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Oculis Holding's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Oculis Holding's managers, analysts, and investors.Environmental | Governance | Social |
Oculis Fundamentals
| Return On Equity | -0.92 | ||||
| Return On Asset | -0.33 | ||||
| Operating Margin | (83.52) % | ||||
| Current Valuation | 1.46 B | ||||
| Shares Outstanding | 57.81 M | ||||
| Shares Owned By Insiders | 2.75 % | ||||
| Shares Owned By Institutions | 45.15 % | ||||
| Number Of Shares Shorted | 344.72 K | ||||
| Price To Book | 9.80 X | ||||
| Price To Sales | 2,081 X | ||||
| Revenue | 686 K | ||||
| Gross Profit | (54.77 M) | ||||
| EBITDA | (72.8 M) | ||||
| Net Income | (85.94 M) | ||||
| Total Debt | 1.18 M | ||||
| Book Value Per Share | 3.21 X | ||||
| Cash Flow From Operations | (47.5 M) | ||||
| Short Ratio | 2.06 X | ||||
| Earnings Per Share | (2.78) X | ||||
| Target Price | 45.67 | ||||
| Number Of Employees | 49 | ||||
| Beta | 0.15 | ||||
| Market Capitalization | 1.65 B | ||||
| Total Asset | 120.35 M | ||||
| Retained Earnings | (285.56 M) | ||||
| Working Capital | 60.66 M | ||||
| Net Asset | 120.35 M |
About Oculis Holding Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Oculis Holding AG's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Oculis Holding using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Oculis Holding AG based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Oculis Stock Analysis
When running Oculis Holding's price analysis, check to measure Oculis Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oculis Holding is operating at the current time. Most of Oculis Holding's value examination focuses on studying past and present price action to predict the probability of Oculis Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oculis Holding's price. Additionally, you may evaluate how the addition of Oculis Holding to your portfolios can decrease your overall portfolio volatility.